{"id":10503,"date":"2025-03-16T13:52:22","date_gmt":"2025-03-16T13:52:22","guid":{"rendered":"https:\/\/www.essecieffe.it\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/"},"modified":"2026-05-15T11:32:21","modified_gmt":"2026-05-15T11:32:21","slug":"criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms","status":"publish","type":"post","link":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/","title":{"rendered":"Criteria for the assessment of therapeutic innovativeness and management of anti\u2011infective agents in infections caused by multidrug\u2011resistant organisms"},"content":{"rendered":"<p>The Italian Medicines Agency makes available a reference document dedicated to the criteria for assessing therapeutic innovativeness and to the modalities for managing anti\u2011infective agents used in the treatment of infections caused by multidrug\u2011resistant organisms.<\/p>\n<p>The text provides operational and methodological guidance to ensure a uniform and transparent approach in the assessment of new medicines, with particular attention to therapies aimed at addressing the growing challenge of antimicrobial resistance. The objective is to promote the appropriate and responsible use of antimicrobials, supporting stewardship strategies and enhancing innovative diagnostic and therapeutic tools.<\/p>\n<p><span>This initiative is part of national and international policies aimed at strengthening patient safety and supporting independent research, contributing to a more effective and sustainable healthcare system.<\/span><\/p>\n<p>For further information and to consult the full document, the following link is available:<a href=\"https:\/\/www.essecieffe.it\/wp-content\/uploads\/2025\/11\/Bozza-criteri-innovativita-pubblicato-12-marzo-2025.pdf\"> Draft criteria for innovativeness published on 12 March 2025<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Italian Medicines Agency makes available a reference document dedicated to the criteria for assessing therapeutic innovativeness and to the modalities for managing anti\u2011infective agents used in the treatment of infections caused by multidrug\u2011resistant organisms. The text provides operational and methodological guidance to ensure a uniform and transparent approach in the assessment of new medicines,&#8230;<\/p>\n","protected":false},"author":5,"featured_media":10505,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[28],"tags":[29],"class_list":["post-10503","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-aifanews"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Criteria for the assessment of therapeutic innovativeness and management of anti\u2011infective agents in infections caused by multidrug\u2011resistant organisms - Studio Consulenza Farmacologica<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Criteria for the assessment of therapeutic innovativeness and management of anti\u2011infective agents in infections caused by multidrug\u2011resistant organisms - Studio Consulenza Farmacologica\" \/>\n<meta property=\"og:description\" content=\"The Italian Medicines Agency makes available a reference document dedicated to the criteria for assessing therapeutic innovativeness and to the modalities for managing anti\u2011infective agents used in the treatment of infections caused by multidrug\u2011resistant organisms. The text provides operational and methodological guidance to ensure a uniform and transparent approach in the assessment of new medicines,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/\" \/>\n<meta property=\"og:site_name\" content=\"Studio Consulenza Farmacologica\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-16T13:52:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-15T11:32:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.essecieffe.it\/wp-content\/uploads\/2025\/11\/immagine-scf-news-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"683\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Emanuele Bertino\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emanuele Bertino\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\\\/\"},\"author\":{\"name\":\"Emanuele Bertino\",\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/#\\\/schema\\\/person\\\/257c57107e36fd56832d254997e77aa7\"},\"headline\":\"Criteria for the assessment of therapeutic innovativeness and management of anti\u2011infective agents in infections caused by multidrug\u2011resistant organisms\",\"datePublished\":\"2025-03-16T13:52:22+00:00\",\"dateModified\":\"2026-05-15T11:32:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\\\/\"},\"wordCount\":161,\"publisher\":{\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.essecieffe.it\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/immagine-scf-news-1.png\",\"keywords\":[\"AIFAnews\"],\"articleSection\":[\"news\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\\\/\",\"url\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\\\/\",\"name\":\"Criteria for the assessment of therapeutic innovativeness and management of anti\u2011infective agents in infections caused by multidrug\u2011resistant organisms - Studio Consulenza Farmacologica\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.essecieffe.it\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/immagine-scf-news-1.png\",\"datePublished\":\"2025-03-16T13:52:22+00:00\",\"dateModified\":\"2026-05-15T11:32:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.essecieffe.it\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/immagine-scf-news-1.png\",\"contentUrl\":\"https:\\\/\\\/www.essecieffe.it\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/immagine-scf-news-1.png\",\"width\":1024,\"height\":683},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/home-def\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Criteria for the assessment of therapeutic innovativeness and management of anti\u2011infective agents in infections caused by multidrug\u2011resistant organisms\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/#website\",\"url\":\"https:\\\/\\\/www.essecieffe.it\\\/\",\"name\":\"Studio Consulenza Farmacologica\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.essecieffe.it\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/#organization\",\"name\":\"Studio Consulenza Farmacologica\",\"url\":\"https:\\\/\\\/www.essecieffe.it\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.essecieffe.it\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/logoscf-favicon.jpg\",\"contentUrl\":\"https:\\\/\\\/www.essecieffe.it\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/logoscf-favicon.jpg\",\"width\":432,\"height\":432,\"caption\":\"Studio Consulenza Farmacologica\"},\"image\":{\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.essecieffe.it\\\/#\\\/schema\\\/person\\\/257c57107e36fd56832d254997e77aa7\",\"name\":\"Emanuele Bertino\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b853c59b1096cf4e3846b17f10247d88067a5e830ca6dc93a4b69942e23c9956?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b853c59b1096cf4e3846b17f10247d88067a5e830ca6dc93a4b69942e23c9956?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b853c59b1096cf4e3846b17f10247d88067a5e830ca6dc93a4b69942e23c9956?s=96&d=mm&r=g\",\"caption\":\"Emanuele Bertino\"},\"url\":\"https:\\\/\\\/www.essecieffe.it\\\/en\\\/author\\\/emanuele\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Criteria for the assessment of therapeutic innovativeness and management of anti\u2011infective agents in infections caused by multidrug\u2011resistant organisms - Studio Consulenza Farmacologica","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/","og_locale":"en_US","og_type":"article","og_title":"Criteria for the assessment of therapeutic innovativeness and management of anti\u2011infective agents in infections caused by multidrug\u2011resistant organisms - Studio Consulenza Farmacologica","og_description":"The Italian Medicines Agency makes available a reference document dedicated to the criteria for assessing therapeutic innovativeness and to the modalities for managing anti\u2011infective agents used in the treatment of infections caused by multidrug\u2011resistant organisms. The text provides operational and methodological guidance to ensure a uniform and transparent approach in the assessment of new medicines,...","og_url":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/","og_site_name":"Studio Consulenza Farmacologica","article_published_time":"2025-03-16T13:52:22+00:00","article_modified_time":"2026-05-15T11:32:21+00:00","og_image":[{"width":1024,"height":683,"url":"https:\/\/www.essecieffe.it\/wp-content\/uploads\/2025\/11\/immagine-scf-news-1.png","type":"image\/png"}],"author":"Emanuele Bertino","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Emanuele Bertino","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/#article","isPartOf":{"@id":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/"},"author":{"name":"Emanuele Bertino","@id":"https:\/\/www.essecieffe.it\/#\/schema\/person\/257c57107e36fd56832d254997e77aa7"},"headline":"Criteria for the assessment of therapeutic innovativeness and management of anti\u2011infective agents in infections caused by multidrug\u2011resistant organisms","datePublished":"2025-03-16T13:52:22+00:00","dateModified":"2026-05-15T11:32:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/"},"wordCount":161,"publisher":{"@id":"https:\/\/www.essecieffe.it\/#organization"},"image":{"@id":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/#primaryimage"},"thumbnailUrl":"https:\/\/www.essecieffe.it\/wp-content\/uploads\/2025\/11\/immagine-scf-news-1.png","keywords":["AIFAnews"],"articleSection":["news"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/","url":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/","name":"Criteria for the assessment of therapeutic innovativeness and management of anti\u2011infective agents in infections caused by multidrug\u2011resistant organisms - Studio Consulenza Farmacologica","isPartOf":{"@id":"https:\/\/www.essecieffe.it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/#primaryimage"},"image":{"@id":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/#primaryimage"},"thumbnailUrl":"https:\/\/www.essecieffe.it\/wp-content\/uploads\/2025\/11\/immagine-scf-news-1.png","datePublished":"2025-03-16T13:52:22+00:00","dateModified":"2026-05-15T11:32:21+00:00","breadcrumb":{"@id":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/#primaryimage","url":"https:\/\/www.essecieffe.it\/wp-content\/uploads\/2025\/11\/immagine-scf-news-1.png","contentUrl":"https:\/\/www.essecieffe.it\/wp-content\/uploads\/2025\/11\/immagine-scf-news-1.png","width":1024,"height":683},{"@type":"BreadcrumbList","@id":"https:\/\/www.essecieffe.it\/en\/criteria-for-the-assessment-of-therapeutic-innovativeness-and-management-of-anti-infective-agents-in-infections-caused-by-multidrug-resistant-organisms\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.essecieffe.it\/en\/home-def\/"},{"@type":"ListItem","position":2,"name":"Criteria for the assessment of therapeutic innovativeness and management of anti\u2011infective agents in infections caused by multidrug\u2011resistant organisms"}]},{"@type":"WebSite","@id":"https:\/\/www.essecieffe.it\/#website","url":"https:\/\/www.essecieffe.it\/","name":"Studio Consulenza Farmacologica","description":"","publisher":{"@id":"https:\/\/www.essecieffe.it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.essecieffe.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.essecieffe.it\/#organization","name":"Studio Consulenza Farmacologica","url":"https:\/\/www.essecieffe.it\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.essecieffe.it\/#\/schema\/logo\/image\/","url":"https:\/\/www.essecieffe.it\/wp-content\/uploads\/2025\/12\/logoscf-favicon.jpg","contentUrl":"https:\/\/www.essecieffe.it\/wp-content\/uploads\/2025\/12\/logoscf-favicon.jpg","width":432,"height":432,"caption":"Studio Consulenza Farmacologica"},"image":{"@id":"https:\/\/www.essecieffe.it\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.essecieffe.it\/#\/schema\/person\/257c57107e36fd56832d254997e77aa7","name":"Emanuele Bertino","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b853c59b1096cf4e3846b17f10247d88067a5e830ca6dc93a4b69942e23c9956?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b853c59b1096cf4e3846b17f10247d88067a5e830ca6dc93a4b69942e23c9956?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b853c59b1096cf4e3846b17f10247d88067a5e830ca6dc93a4b69942e23c9956?s=96&d=mm&r=g","caption":"Emanuele Bertino"},"url":"https:\/\/www.essecieffe.it\/en\/author\/emanuele\/"}]}},"_links":{"self":[{"href":"https:\/\/www.essecieffe.it\/en\/wp-json\/wp\/v2\/posts\/10503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.essecieffe.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.essecieffe.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.essecieffe.it\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.essecieffe.it\/en\/wp-json\/wp\/v2\/comments?post=10503"}],"version-history":[{"count":1,"href":"https:\/\/www.essecieffe.it\/en\/wp-json\/wp\/v2\/posts\/10503\/revisions"}],"predecessor-version":[{"id":10524,"href":"https:\/\/www.essecieffe.it\/en\/wp-json\/wp\/v2\/posts\/10503\/revisions\/10524"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.essecieffe.it\/en\/wp-json\/wp\/v2\/media\/10505"}],"wp:attachment":[{"href":"https:\/\/www.essecieffe.it\/en\/wp-json\/wp\/v2\/media?parent=10503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.essecieffe.it\/en\/wp-json\/wp\/v2\/categories?post=10503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.essecieffe.it\/en\/wp-json\/wp\/v2\/tags?post=10503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}